LUMBERTON — A Lumberton nonprofit has been selected to receive a $25,000 grant from Google and will work alongside the tech giant to develop new uses for its innovative Glass headset.
On Wednesday, Google announced that 3,000 Miles for a Cure was among five organizations picked to receive funding through its Giving through Glass initiative, described by the company as a way to help nonprofits “amplify their impact.”
Cyclist Maria Parker founded 3,000 Miles for a Cure in 2013 to raise money for brain cancer research after her sister, who passed away last month, was diagnosed with the disease.
The organization’s name was inspired by Parker’s participation in the annual Race Across America competition, where she peddled 3,002 miles from California to Maryland in 11 days. She was the first woman to cross the finish line and set a course record, despite being sidelined for a day after a traffic accident involving her support crew.
RAAM officials declared her performance the “greatest comeback” in the competition’s 32-year history.
Parker and her team plan to use the grant to outfit future RAAM participants with headsets, which will be used to document their progress and share information with their support crews.
The organization’s grant proposal was one of more than 1,300 submitted to Google following an open call from the company in April.
“There was a pretty lengthy application process,” said Carly Redfern, a public relations representative for 3,000 Miles for a Cure. “We started in May and got a phone call from Google. They wanted to make sure our project was unique and showed a different aspect of Google Glass.”
The other organizations selected for the grant include Mark Morris Dance Group of New York; Women’s Audio Mission of San Francisco; Classroom Champions of Florida; and Hearing and Speech Agency of Maryland.
“We are incredibly honored to be chosen as a Giving through Glass recipient and we are eager to explore the incredible potential of this technology as a platform for athletes to fund raise for brain cancer research,” Parker said in a statement.